Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

MRC offers Fv1 gene for licensing

Dec. 17, 1996

New HIV-1 protease inhibitor in development at LG Chemical

Dec. 13, 1996

Procept's topical microbicide enters phase I in Europe

Dec. 12, 1996

Italian researchers described novel anti-HIV compounds

Dec. 12, 1996

Merck Frosst's apopain inhibitors: A novel approach to multiple disorders

Dec. 10, 1996

NIH offers invention for treating and diagnosing HIV infection for licensing

Dec. 4, 1996

NIH offers licenses for invention related to fusin

Dec. 4, 1996

Promising clinical results reported for C. parvum therapeutic

Dec. 4, 1996

Another European market introduction for Epivir

Nov. 28, 1996

Purified or recombinant TAP 29 with anti-HIV activity available for licensing

Nov. 28, 1996

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...